Product
D013
Aliases
D013, D326, D337
3 clinical trials
1 indication
Indication
Hypertension and DyslipidemiaClinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-386(3) With Co-administration of D013, D326, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-06-06
Clinical trial
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-386 With Co-administration of D013, D326, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-11-27
Clinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and the Tolerability of CKD-386(5) With Co-administration of D013, D326, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-09-01